The ischemic stroke market was valued at USD 5.27 Billion in 2025 and is expected to grow at a CAGR of 7.13%, reaching USD 10.49 Billion by 2035. The market growth is driven by growing elderly population, increasing incidence of cardiovascular risk factors, and improvements in acute care protocols.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
7.13%
Value in USD Billion
2026-2035
*this image is indicative*
Ischemic stroke occurs due to blockage in the arteries that supplies blood to the brain. This type of stroke accounts for 87% of all strokes and causes damage to the brain cells. A recent study estimated the global age-standardized incidence rate of ischemic stroke is expected to increase to 89.32 per 100,000 individuals by 2030, with the projections indicating a higher occurrence in women than men. This rising incidence of the condition is anticipated to drive the ischemic stroke market growth in the near future.
In August 2023 , Enspire DBS Therapy, Inc., secured USD 17.6 million in Series B funding led by Cleveland Clinic Innovations to support the development of its deep brain stimulation (DBS) and rehabilitation therapy for stroke patients. The funds will be primarily utilized for the clinical trial RESTORE, which aims to investigate DBS and rehab therapy’s efficacy in treating chronic upper extremity impairment due to stroke and generate sufficient data for market approval. A previous trial known as EDEN (Electrical Stimulation of the Dentate Nucleus for Upper Extremity Hemiparesis Due to Ischemic Stroke) showed positive results that prompted the Series B raise. Such investments in innovative neuro-stimulation solutions address a specific clinical need and are expected to fuel the ischemic stroke market demand in the forecast period.
The market is also driven by the growing preference for non-invasive procedures to treat and manage ischemic stroke. Moreover, the rise in public health campaigns and heightened patient awareness will fuel market growth.
"Ischemic Stroke Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Market Breakup by Indication Type
The market is segmented by indication type into large artery thrombosis (LAT), cardioembolic stroke, lacunar stroke, and cryptogenic stroke. LAT involves major artery blockage whereas cardioembolic strokes are caused by clots originating in the heart.
Market Breakup by Diagnosis Type
The market segmentation by diagnosis type for ischemic stroke comprises imaging techniques (MRI, CT scans, and angiography) to visualize brain structures and blood vessels, blood tests for biomarker analysis, and electrocardiography (ECG/EKG) to detect heart abnormalities.
Market Breakup by Treatment Type
By treatment type, the ischemic stroke market share includes thrombolytic therapy, endovascular procedures, anticoagulants and antiplatelet drugs, neuroprotective agents, rehabilitation therapies, along with surgical interventions. Thrombolytic therapy is used to dissolve clots and endovascular procedures are carried out for clot removal. Anticoagulants and antiplatelet drugs help to prevent clot formation.
Market Breakup by End User
End users of the market are hospitals and clinics, ambulatory surgical centers (ASCs), and rehabilitation centers.
Market Breakup by Region
Based on the region, the market includes the United States, EU-4 (Germany, France, Italy, Spain), the United Kingdom, Japan, and China. The United States dominates the market share, which can be attributed to a well-developed research infrastructure, which further boosts the treatment landscape. Asia Pacific is poised to witness significant growth, owing to rising investments from public and private institutions, aimed at improving the healthcare infrastructure.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is anticipated to grow at a CAGR of 7.13% during the forecast period of 2026-2035, driven by the rising prevalence of ischemic stroke risk factors such as hypertension, diabetes, obesity, and sedentary lifestyle across the 8 major markets.
The market demand is driven by the growing preference for minimally invasive procedures for the treatment of ischemic stroke, along with advancements in diagnostic imaging.
One of the significant trends in the market is the rising investments in innovative therapies to treat ischemic stroke. In August 2023 , Enspire DBS Therapy, Inc. secured USD 17.6 million to support the development of its deep brain stimulation (DBS) and rehabilitation therapy for stroke patients.
Based on the indication type, the market is segmented into large artery thrombosis (LAT), cardioembolic stroke, lacunar stroke, and cryptogenic stroke.
Based on the treatment type, the market is segmented into thrombolytic therapy, endovascular procedures, anticoagulant and antiplatelet drugs, neuroprotective agents, rehabilitation therapies, and surgical interventions.
Major end users of the market are hospitals and clinics, ambulatory surgical centers (ASCs), and rehabilitation centers.
The market segmentation by diagnosis type for ischemic stroke comprises imaging techniques (MRI, CT scans, and angiography), blood tests, and electrocardiography (ECG/EKG).
The major regions of the market include the United States, EU-4 (Germany, France, Italy, Spain), the United Kingdom, Japan, and China.
Key players involved in the market are Medtronic plc, Genentech, Inc., GE Healthcare, Covidien plc, Cordis Corporation, Boston Scientific Corporation, Boehringer Ingelheim, Bayer AG, Abbott Laboratories, Johnson & Johnson, Swiss Pharma Pvt. Ltd., Bristol Myers Squibb, Pfizer, Eli Lilly and Company, and GlaxoSmithKline.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Indication Type |
|
| Breakup by Diagnosis Type |
|
| Breakup by Treatment Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share